Kincell Bio Revenue and Competitors
Estimated Revenue & Valuation
- Kincell Bio's estimated annual revenue is currently $15.1M per year.
- Kincell Bio's estimated revenue per employee is $201,000
- Kincell Bio's total funding is $36M.
Employee Data
- Kincell Bio has 75 Employees.
- Kincell Bio grew their employee count by 44% last year.
Kincell Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Technology Officer | Reveal Email/Phone |
2 | Chief Technology Officer | Reveal Email/Phone |
3 | VP Technical Operations | Reveal Email/Phone |
4 | Director Information Technology | Reveal Email/Phone |
5 | Quality Assurance | Reveal Email/Phone |
Kincell Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $32.2M | 160 | N/A | N/A | N/A |
#2 | $15.1M | 75 | 23% | N/A | N/A |
#3 | $341.9M | 1701 | N/A | N/A | N/A |
#4 | $16.7M | 83 | 43% | N/A | N/A |
#5 | $10.9M | 54 | -4% | N/A | N/A |
#6 | $11.3M | 56 | -2% | N/A | N/A |
#7 | $211.7M | 1297 | 4% | N/A | N/A |
#8 | $29.1M | 145 | 5% | N/A | N/A |
#9 | $9.4M | 47 | -2% | N/A | N/A |
#10 | $11.9M | 59 | -8% | N/A | N/A |
What Is Kincell Bio?
Kincell is a technology-forward contract development and manufacturing organization (CDMO) that streamlines analytical development, process development, CMC consulting and GMP cell therapy manufacturing. Our focus is on developing and manufacturing immune cell therapies, including autologous and allogeneic CAR-T, CAR-NK, and CAR-M programs. For more information, please visit our website at www.kincellbio.com.
keywords:N/A$36M
Total Funding
75
Number of Employees
$15.1M
Revenue (est)
44%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $16.9M | 75 | 17% | N/A |
#2 | $10.6M | 76 | 58% | N/A |
#3 | $15.3M | 76 | 10% | N/A |
#4 | $13.2M | 77 | 28% | N/A |
#5 | $11.2M | 77 | -22% | N/A |